A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose

A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. J L Parkes , S L Slatin , S Pardo and B H Ginsberg Becton Dickinson and Company, Franklin Lakes, New Jersey 07417, USA. joan_parkes@bd.com Abstract OBJECTIVE: The objectives of this...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes care Vol. 23; no. 8; pp. 1143 - 1148
Main Authors: PARKES, J. L, SLATIN, S. L, PARDO, S, GINSBERG, B. H
Format: Journal Article
Language:English
Published: Alexandria, VA American Diabetes Association 01-08-2000
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. J L Parkes , S L Slatin , S Pardo and B H Ginsberg Becton Dickinson and Company, Franklin Lakes, New Jersey 07417, USA. joan_parkes@bd.com Abstract OBJECTIVE: The objectives of this study were 1) to construct new error grids (EGs) for blood glucose (BG) self-monitoring by using the expertise of a large panel of clinicians and 2) to use the new EGs to evaluate the accuracy of BG measurements made by patients. RESEARCH DESIGN AND METHODS: To construct new EGs for type 1 and type 2 diabetic patients, a total of 100 experts of diabetes were asked to assign any error in BG measurement to 1 of 5 risk categories. We used these EGs to evaluate the accuracy of self-monitoring of blood glucose (SMBG) levels in 152 diabetic patients. The SMBG data were used to compare the new type 1 diabetes EG with a traditional EG. RESULTS: Both the type 1 and type 2 diabetes EGs divide the risk plane into 8 concentric zones with no discontinuities. The new EGs are similar to each other, but they differ from the traditional EG in several significant ways. When used to evaluate a data set of measurements made by a sample of patients experienced in SMBG, the new type 1 diabetes EG rated 98.6% of their measurements as clinically acceptable, compared with 95% for the traditional EG. CONCLUSIONS: The consensus EGs furnish a new tool for evaluating errors in the measurement of BG for patients with type 1 and type 2 diabetes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0149-5992
1935-5548
DOI:10.2337/diacare.23.8.1143